دورية أكاديمية
How we forecast tomorrow's haemovigilance.
| العنوان: | How we forecast tomorrow's haemovigilance. |
|---|---|
| المؤلفون: | Wood EM; School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria 3004, Australia; Department of Clinical Haematology, Monash Health, Clayton Road, Clayton, Victoria 3168, Australia. Electronic address: erica.wood@monash.edu., Whitaker BI; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, White Oak-71, Silver Spring, MD 20993, USA. Electronic address: Barbee.Whitaker@fda.hhs.gov., Townsend M; Vitalant, 9503 E Via de Ventura, Scottsdale, AZ 85259, USA. Electronic address: mtownsend@vitalant.org., Narayan S; Serious Hazards of Transfusion (SHOT), NHS Blood and Transplant, Manchester Blood Centre, Manchester M13 9LL, United Kingdom. Electronic address: Shruthi.Narayan@nhsbt.nhs.uk. |
| المصدر: | Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2024 May; Vol. 31 (2), pp. 114-118. Date of Electronic Publication: 2024 Mar 07. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Science Country of Publication: France NLM ID: 9423846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1953-8022 (Electronic) Linking ISSN: 12467820 NLM ISO Abbreviation: Transfus Clin Biol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Paris : Elsevier Science Original Publication: Paris : Arnette Blackwell, c1994- |
| مواضيع طبية MeSH: | Blood Safety*/methods , Blood Transfusion*, Humans ; Blood Banks ; Blood Donors ; Forecasting |
| مستخلص: | The field of haemovigilance continues to develop, building on more than forty years of international experience. This review considers the current scope and activities of haemovigilance around the world and explores aspects of preparation for the advent of new blood products and alternative therapies to transfusion; new tools for data acquisition (including patient- and donor-reported outcomes, and data from 'wearables') and the analysis and communication of haemovigilance results. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 Société française de transfusion sanguine (SFTS). All rights reserved.) |
| فهرسة مساهمة: | Keywords: Adverse reactions; Blood transfusion; Haemovigilance; Patient safety |
| تواريخ الأحداث: | Date Created: 20240309 Date Completed: 20240422 Latest Revision: 20240422 |
| رمز التحديث: | 20240422 |
| DOI: | 10.1016/j.tracli.2024.03.001 |
| PMID: | 38460837 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1953-8022 |
|---|---|
| DOI: | 10.1016/j.tracli.2024.03.001 |